Chloroquine sensitivity of Plasmodium vivax in Thailand.
Chloroquine has been the standard treatment for Plasmodium vivax malaria for more than 40 years in most regions of the world. Recently, however, chloroquine-resistant P. vivax has been reported from Oceania, several parts of Asia, and South America. In order to assess the situation in Thailand, 886...
Main Authors: | Looareesuwan, S, Wilairatana, P, Krudsood, S, Treeprasertsuk, S, Singhasivanon, P, Bussaratid, V, Chokjindachai, W, Viriyavejakul, P, Chalermrut, K, Walsh D, S, White, J |
---|---|
Formato: | Journal article |
Idioma: | English |
Publicado em: |
1999
|
Registos relacionados
-
Clinical trial of oral artesunate with or without high-dose primaquine for the treatment of vivax malaria in Thailand.
Por: Silachamroon, U, et al.
Publicado em: (2003) -
Dihydroartemisinin-piperaquine versus chloroquine in the treatment of Plasmodium vivax malaria in Thailand: a randomized controlled trial.
Por: Phyo, A, et al.
Publicado em: (2011) -
Chloroquine resistance in Plasmodium vivax.
Por: Baird, J
Publicado em: (2004) -
Plasmodium vivax trophozoites insensitive to chloroquine.
Por: Sharrock, W, et al.
Publicado em: (2008) -
Chloroquine sensitive Plasmodium falciparum and P. vivax in central Java, Indonesia.
Por: Baird, J, et al.
Publicado em: (1996)